Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 4
A review of anti-IgE monoclonal antibody (omalizumab) as add on therapy for severe allergic (IgE-mediated) asthma
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,674 | Dovepress* | 5,674+ | 2,167 | 7,841 | |
| Totals | 5,674 | 2,167 | 7,841 | ||
|
*Since 15 September 2007 +Since July 2016 |
|||||
View citations on Google Scholar